Meg Tully
Meg Tully has a Masters of Biostatistics from the University of Melbourne and is currently undertaking a PhD specialising in novel antimalarial combination therapies to combat the ongoing threat of drug resistance. She is based in the Centre for Epidemiology and Biostatistics within the Melbourne School of Population and Global Health and supervised by Prof Julie Simpson, Dr David Price and Dr Rob Commons. Her research is currently focused on pharmacokinetic-pharmacodynamic modelling of the within-host dynamics of malaria treatments.
Publications:
Tully MK, Commons RJ, Simpson JA, Price DJ. 2026. Quantification of cure for pharmacodynamic models of antimalarial drugs: Deterministic versus stochastic approaches. Br J Clin Pharmacol.;92(1):317-322. doi:10.1002/bcp.70340
Tully MK, Dini S, Flegg JA, McCarthy JS, Price DJ, Simpson JA.2024.Evaluation of a Bayesian hierarchical pharmacokinetic–pharmacodynamic model for predicting parasitological outcomes in Phase 2 studies of new antimalarial drugs. Antimicrob Agents Chemother68:e00863-24.doi:10.1128/aac.00863-24